Literature DB >> 12479277

Trends in aortic valve surgery in a large multi-surgeon, multi-hospital practice, 1979-1999.

William F Northrup1, Karen A Dubois, Vibhu R Kshettry, John M Teskey, Demetre M Nicoloff.   

Abstract

BACKGROUND AND AIM OF THE STUDY: Trends in aortic valve operations (AVO) may help to predict the future of aortic valve surgery in the context of changing case mix, population demographics, emerging technology and shifting paradigms.
METHODS: All adults undergoing single AVO between 1979 and 1999 were reviewed retrospectively according to age, gender and other typical clinical variables, surgical complexity, specific operation and immediate outcome.
RESULTS: There were 3,917 single AVO. Although coronary artery bypass (CAB) volumes declined by 15.3% between 1996 and 1999, AVO volumes have continued to increase by 11.7% since 1996. Over the entire period, there was no significant change in mean age or percent female gender, but increases in the prevalence of octogenarians and aortic stenosis were noted. During the 1990s, degenerative valve disease predominated and the prevalence of sicker patients according to heart failure class and surgical priority decreased. Trends in surgical complexity included an increase in AVO combined with CAB, but a stable 9:1 distribution of first operations to reoperations. Technology adoption included a decreased prevalence of mechanical valve use at the expense of increased use of tissue valves, especially stented xenografts and homografts. Transient technology adoption included stentless xenografts. Small numbers of pulmonary autografts, aortic valve repairs and valve-sparing aortic replacements were carried out. Predictors of hospital mortality rates for AVO included age 65 years, reoperation and combined AVO. Hospital mortality rates for AVO decreased for most age groups between the 1980s and 1990s, but not during the 1990s.
CONCLUSION: AVO volumes are steadily increasing, apparently as a result of the increase in octogenarians and the start of the 'baby boom' wave. Hospital mortality risk is related to age and surgical complexity, but is modest and has stabilized during the past decade. The prevalence of mechanical valve implants has decreased in favor of tissue valve replacement categories. The fastest growth rates have been with stented xenografts, and especially homografts. This may represent a paradigm shift away from mechanical solutions in favor of tissue solutions for aortic valve disease.

Entities:  

Mesh:

Year:  2002        PMID: 12479277

Source DB:  PubMed          Journal:  J Heart Valve Dis        ISSN: 0966-8519


  5 in total

1.  Endothelial retention and phenotype on carbonized cardiovascular implant surfaces.

Authors:  Christopher M Frendl; Scott M Tucker; Nadeem A Khan; Mandy B Esch; Shrinidhi Kanduru; Thong M Cao; Andrés J García; Michael R King; Jonathan T Butcher
Journal:  Biomaterials       Date:  2014-06-20       Impact factor: 12.479

Review 2.  Insights into the use of biomarkers in calcific aortic valve disease.

Authors:  Erik Beckmann; Juan B Grau; Rachana Sainger; Paolo Poggio; Giovanni Ferrari
Journal:  J Heart Valve Dis       Date:  2010-07

3.  Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls.

Authors:  Paolo Poggio; Juan B Grau; Benjamin C Field; Rachana Sainger; William F Seefried; Flavio Rizzolio; Giovanni Ferrari
Journal:  J Cell Physiol       Date:  2011-08       Impact factor: 6.384

4.  Trends in mechanical aortic valve replacement surgery in a large, multi-surgeon, single hospital practice.

Authors:  Mehmet Kalender; Ali Fedakar; Taylan Adademir; Salih Salihi; Kamil Boyacıoğlu; Babürhan Özbek; Mehmet Taşar; Mehmet Balkanay
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-11-30

5.  Isolated tricuspid valve surgery; long-term outcomes based on Tehran Heart Center data bank report.

Authors:  Seyed Hosssein Ahmadi Tafti; Farshid Alaeddini; Mahmood Shirzad; Jamshid Bagheri; Abbas Salehi Omran; Mehrdad Mahalleh; Shiva Shoja; Negar Omidi
Journal:  J Cardiothorac Surg       Date:  2021-02-23       Impact factor: 1.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.